Skip to main content

Research

New research
Research history

Explore

Search
Cases
Professionals

Resources

Blog
Pricing
Docs

Sign in Create account

Cases

CourtFilingsPetition dateMore filters

Case

Funded debt

Stage

Exit

Next hearing

Last activity

Petition date

Court

MiddleBrook Pharmaceuticals, Inc. Bankruptcy Case

MiddleBrook Pharmaceuticals, Inc.

Sale Process

Case No. 10-11485·Delaware·Petition date Apr 30, 2010

Research this case Track this case Sign in

OverviewProfessionals

Key professionals

Financial Advisor

Gleacher & Company Securities, Inc.

Financial Advisor

Invotex Group

Judge: Mary F. Walrath
Industry: Pharmaceuticals

MiddleBrook Pharmaceuticals, Inc. is a Germantown, Maryland-based pharmaceutical company founded in 1996 that focuses on the development and commercialization of novel anti-infective products. The company’s primary product is MOXATAG™, the first FDA-approved once-daily amoxicillin, which launched in 2009 for the treatment of pharyngitis and tonsillitis in adult and pediatric patients. Following a strategic workforce reduction, the company operates with a staff of 15 employees to manage its pharmaceutical assets and product portfolio.

Case background, summaries, and key terms are generated from the filings on this docket. Docket entries and documents come from the court.

Report a data error